DE:7D2A Stock Latest News
Company AnnouncementsSedana Medical Returns to Sales Growth but Continues to Invest Heavily in Expansion1w ago
Pre-Earnings7D2A Upcoming Earnings Report: What to Expect?1w ago
Company AnnouncementsSedana Medical Sets Date for Q3 2026 Interim Report and Investor Presentation2w ago
Company AnnouncementsSedana Medical Sets 2027 AGM Nomination Committee Representing Major Shareholders2w ago
Company AnnouncementsSedana Medical Secures FDA PDUFA Date for Inhaled ICU Sedation Therapy2M ago
Company AnnouncementsSedana Medical Wins FDA Review of Inhaled Sedation Drug for ICU Use2M ago
Company AnnouncementsSedana Medical Sets July 17 Date for Q2 2026 Interim Report and Investor Presentation4M ago
Company AnnouncementsSedana Medical Names Mikael Haag as New CFO to Drive Expansion4M ago
Company AnnouncementsSedana Medical Files FDA NDA for First Inhaled ICU Sedation Therapy in U.S.4M ago
Company AnnouncementsSedana Medical AGM Backs No-Dividend Policy, New Share Mandate and Incentive Plan5M ago
Company AnnouncementsSedana Medical Calls AGM to Vote on Governance and New Incentive Plan6M ago
Company AnnouncementsSedana Medical Posts Record Sales and Advances Toward U.S. ICU Sedation Market6M ago
- Company AnnouncementsSedana Medical sets April 23 date for first‑quarter 2026 results and investor presentation6M ago
Company AnnouncementsSedana Medical Treats First U.S. Patient in FDA-Approved Early Access Sedation Program7M ago- Company AnnouncementsSedana Medical Narrows Losses and Turns Ex-US EBITDA Positive Amid 2025 Sales Growth8M ago
- Company AnnouncementsSedana Medical Schedules Q4 2025 Interim Report Release and Investor Presentation9M ago
Company AnnouncementsSedana Medical Strengthens Leadership with New CFO Ahead of US Expansion9M agoCompany AnnouncementsSedana Medical Achieves Positive FDA Pre-NDA Meeting for Inhaled Sedation11M ago